Lifeline Scientific (LSE:LSI) Inventory-to-Revenue : 0.32 (As of Jun. 2016)

View and export this data going back to . Start your Free Trial

What is Lifeline Scientific Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Lifeline Scientific's Average Total Inventories for the quarter that ended in Jun. 2016 was £4.09 Mil. Lifeline Scientific's Revenue for the six months ended in Jun. 2016 was £12.80 Mil. Lifeline Scientific's Inventory-to-Revenue for the quarter that ended in Jun. 2016 was 0.32.

Lifeline Scientific's Inventory-to-Revenue for the quarter that ended in Jun. 2016 increased from Dec. 2015 (0.24) to Dec. 2015 (0.32)

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Lifeline Scientific's Days Inventory for the six months ended in Jun. 2016 was 157.02.

Inventory Turnover measures how fast the company turns over its inventory within a year. Lifeline Scientific's Inventory Turnover for the quarter that ended in Jun. 2016 was 1.16.

Lifeline Scientific Inventory-to-Revenue Historical Data

The historical data trend for Lifeline Scientific's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifeline Scientific Inventory-to-Revenue Chart

Lifeline Scientific Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Inventory-to-Revenue

Get a 7-Day Free Trial

0.07

0.11

0.15

0.16

0.14

Lifeline Scientific Semi-Annual Data
	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16
Inventory-to-Revenue	Get a 7-Day Free Trial										0.38	0.29	0.42	0.24	0.32

Competitive Comparison of Lifeline Scientific's Inventory-to-Revenue

For the Medical Devices subindustry, Lifeline Scientific's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lifeline Scientific's Inventory-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lifeline Scientific's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Lifeline Scientific's Inventory-to-Revenue falls into.

Lifeline Scientific Inventory-to-Revenue Calculation

Lifeline Scientific's Inventory-to-Revenue for the fiscal year that ended in Dec. 2015 is calculated as

	Inventory-to-Revenue (A: Dec. 2015 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Dec. 2014 )	+	Total Inventories (A: Dec. 2015 ))	/	count )	/	Revenue (A: Dec. 2015 )
=	( (3.793	+	3.392)	/	2 )	/	26.31
=	3.5925					/	26.31
=	0.14

Lifeline Scientific's Inventory-to-Revenue for the quarter that ended in Jun. 2016 is calculated as

	Inventory-to-Revenue (Q: Jun. 2016 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Dec. 2015 )	+	Total Inventories (Q: Jun. 2016 ))	/	count )	/	Revenue (Q: Jun. 2016 )
=	( (3.392	+	4.778)	/	2 )	/	12.804
=	4.085					/	12.804
=	0.32

Lifeline Scientific (LSE:LSI) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Lifeline Scientific's Days Inventory for the six months ended in Jun. 2016 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Jun. 2016 )	/	Cost of Goods Sold (Q: Jun. 2016 )	*	Days in Period
	=	4.085	/	4.748	*	365 / 2
	=	157.02

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Lifeline Scientific's Inventory Turnover for the quarter that ended in Jun. 2016 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Jun. 2016 )	/	Average Total Inventories (Q: Jun. 2016 )
	=	4.748	/	4.085
	=	1.16

Lifeline Scientific Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lifeline Scientific's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Lifeline Scientific (LSE:LSI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifeline Scientific Inc (LSE:LSI) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.lifeline-scientific.com

Lifeline Scientific Inc was incorporated on October 1, 1998. The Company is in the business of delivering, to targeted medical markets, a portfolio of related proprietary technologies, which include devices, solutions, and protocols designed to maximize the use and availability of organs, tissues, and cells. It serves the kidney transplant market today with its LifePort product line, and also sells solutions to service the broader organ transplant industry. The Company operates in North America, Brazil, China and Rest of World.